What started as a science fiction idea is now sitting inside billion-dollar boardrooms. At the center of it is Ben Lamm, a tech entrepreneur who has become one of the most talked-about names in modern biotech through his role at Colossal Biosciences.
The company is attempting something unprecedented: using genetic engineering to recreate traits of extinct species like the woolly mammoth. And while there is still no living mammoth or commercial product, Ben Lamm has helped turn the concept of “de-extinction” into a serious investment story.
